PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFeedback Regulatory News (FDBK)

Share Price Information for Feedback (FDBK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 73.50
Bid: 67.00
Ask: 80.00
Change: 3.50 (5.00%)
Spread: 13.00 (19.403%)
Open: 70.00
High: 73.50
Low: 65.00
Prev. Close: 70.00
FDBK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal

3 May 2016 12:00

RNS Number : 0664X
Feedback PLC
03 May 2016
 

3 May 2016

 

Feedback plc

("Feedback" or the "Company")

 

Disposal

 

Feedback plc (AIM: FDBK), the medical imaging software company is pleased to announce that it has agreed to sell its 50% equity interest in Stone Checker Software Ltd ('Stone Checker') to Free Association Books Limited, a company connected to one of Feedback's directors, Trevor Brown, for a cash consideration of £46,000 (the "Disposal").

 

Feedback invested £1,000 in Stone Checker in July 2015 and subsequently licensed its TexRAD software to Stone Checker for exclusive use in urolithiasis (kidney stones). On 28 September 2015, Feedback announced the intention to develop a product incorporating TexRAD for kidney stones. It was further stated that the vision of Stone Checker was to develop a composite risk stratification software product incorporating TexRAD CT texture analysis with other known clinical markers. This integrated product could potentially assist urologists and radiologists to provide better patient management and treatment decisions for improved patient outcomes.

 

Stone Checker is making good progress and is reaching the stage where it will require substantial additional investment. Feedback has already announced that it is committing significant resources in developing a lung cancer stratification tool in conjunction with Alliance Medical Group. Accordingly, although urolithiasis could be an exciting application for TexRAD, the directors of Feedback are of the opinion that they should focus investment in TexRAD's use in oncology. The sale of the equity interest in Stone Checker will generate a profit of £45,000 before expenses. Feedback will continue to receive royalty and licence payments should Stone Checker achieve commercial success. The sale proceeds will be used by Feedback for general corporate purposes.

 

Stone Checker is currently a pre-revenue company which made a loss before tax for the period ending 29 February 2016 of £154.

 

Related Party Transaction

 

Trevor Brown is a director and substantial shareholder in Feedback. Dr Balaji Ganeshan is a director of Stone Checker representing Feedback and is expected to remain a director of both Feedback and Stone Checker after the Disposal. Accordingly, the Disposal constitutes a related party transaction pursuant to Rule 13 of the AIM Rules for Companies ("AIM Rules"). The other three directors of Feedback have no direct involvement in Stone Checker and are not related to the purchaser of Feedback's holding and are therefore deemed to be independent under the AIM Rules for the purposes of considering the related party transaction (the "Independent Directors"). The Independent Directors, having consulted with Allenby Capital Limited, the Company's nominated adviser, consider that the terms of the disposal are fair and reasonable insofar as the Company's shareholders are concerned.

 

For further information, contact:

Feedback plc

Tom Charlton / Mike Hayball

Tel: 01954 718072

 

Allenby Capital Limited (Nominated Adviser and Joint Broker)

Simon Clements / James Thomas

Tel: 020 3328 5656

 

Peterhouse Corporate Finance Ltd (Joint Broker)

Lucy Williams / Duncan Vasey 

Tel: 020 7469 0936

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISAJMMTMBAMBFF
Date   Source Headline
13th Apr 20157:00 amRNSCollaboration with the Oxford Stone Group
27th Feb 20157:00 amRNSAttendance at European Congress of Radiology
13th Feb 20157:00 amRNSHalf Yearly Report
20th Nov 201410:59 amRNSResult of AGM
11th Nov 20141:39 pmRNSTexRAD technology assists in medical trials
30th Oct 20149:16 amRNSPosting of Report & Accounts and Notice of AGM
28th Oct 20147:00 amRNSFinal Results
15th Aug 20142:16 pmRNSDirector/PDMR Shareholding
3rd Jul 201412:17 pmRNSDirector/PDMR Shareholding
30th Jun 20148:00 amRNSDirector/PDMR Shareholding
19th Jun 20142:28 pmRNSChange of Registered Office
16th May 201411:18 amRNSResult of EGM
30th Apr 20149:41 amRNSSchedule 1 - Feedback Plc
30th Apr 20147:01 amRNSAcquisitions Subscription and Admission to Trading
6th Mar 20147:00 amRNSChange of Adviser
19th Feb 20147:00 amRNSHalf Yearly Report
13th Jan 20148:00 amRNSDirectorate Change
20th Dec 20137:00 amRNSHolding(s) in Company
12th Dec 20134:08 pmRNSHolding(s) in Company
12th Dec 20134:07 pmRNSHolding(s) in Company
29th Nov 201312:33 pmRNSResult of AGM
20th Nov 20137:00 amRNSHolding(s) in Company
19th Nov 20137:00 amRNSHolding(s) in Company
12th Nov 20137:01 amRNSHolding(s) in Company
6th Nov 20137:00 amRNSFinal Results
30th Jul 201312:18 pmRNSDisposal of freehold property
29th Jul 201310:46 amRNSResult of General Meeting
11th Jul 20137:00 amRNSDisposal of Freehold Property
3rd Jun 20137:00 amRNSDisposal and Director Change
30th May 201310:50 amRNSResult of General Meeting
14th May 20137:00 amRNSDisposal
13th May 20135:37 pmRNSHolding(s) in Company
19th Mar 20137:00 amRNSAdviser Change of Name
25th Feb 20137:00 amRNSFinal Results
30th Nov 201212:48 pmRNSResult of AGM
12th Nov 20127:00 amRNSDirectorate Change
7th Nov 20127:00 amRNSFinal Results
1st Nov 20127:00 amRNSChange of Registered Office
16th Oct 20127:00 amRNSDirectorate Change
23rd May 20123:58 pmRNSDisposal of Feedback Instruments Limited
11th Apr 20126:27 pmRNSForm 8.3 - Feedback Plc
7th Feb 20127:00 amRNSHalf Yearly Report
24th Nov 20117:00 amRNSDirectors' Shareholding
31st Oct 20116:02 pmRNSTotal Voting Rights
19th Oct 20117:00 amRNSDirector's Shareholding
17th Oct 20117:00 amRNSDirectorate Change
14th Oct 20117:00 amRNSGrant of Options
28th Sep 20117:00 amRNSIssue of Equity
2nd Sep 201111:57 amRNSResult of AGM
29th Jul 20117:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.